Text Size

Study of the Impact of a Pain Diary in Pediatric Patients

This study has been terminated.
(Poor enrollment and data collection)
Sponsor:
Information provided by (Responsible Party):
Andrew Ostrenga, University of Mississippi Medical Center
ClinicalTrials.gov Identifier:
NCT00935207
First received: June 17, 2009
Last updated: May 2, 2013
Last verified: May 2013
History of Changes
  Purpose

The purpose of this study is to show the impact of a pain diary on the communication of pain by pediatric patients. Participants will be given a pain diary after consent and asked to complete the record each time they have pain. A survey about the efficacy of the pain diary will be taken prior to discharge by the nurse, physician, patient and parents. The hypothesis is that the pain diary will improve the communication.


Condition Intervention
Pain
 Other: Pediatric Pain Diary

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: The Impact of a Pain Diary on the Communication of Pain in Pediatric Patients

Further study details as provided by University of Mississippi Medical Center:

Primary Outcome Measures:
  • Child Survey [ Time Frame: Hospital discharge ] [ Designated as safety issue: No ]
  • Parent Survey [ Time Frame: Hospital Discharge ] [ Designated as safety issue: No ]
  • Nurse Survey [ Time Frame: Hospital Discharge ] [ Designated as safety issue: No ]
  • Physician Survey [ Time Frame: Hospital Discharge ] [ Designated as safety issue: No ]

Enrollment: 8
Study Start Date: June 2009
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Pediatric Pain Diary
Patients will be give a pain diary to complete.
 Other: Pediatric Pain Diary
Pain diary designed for pediatric patients

  Eligibility

Ages Eligible for Study:   3 Years to 19 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Inpatients at the Blair E. Batson Hospital for Children 3-19 years of age, receiving regular controlled substance analgesic defined as: codeine with acetaminophen, fentanyl, hydromorphone, meperidine, morphine, oxycodone with acetaminophen, propoxyphene with acetaminophen, and hydrocodone with acetaminophen.

Criteria

Inclusion Criteria:

  • Inpatients at the Blair E. Batson Hospital for Children 3-19 years of age, receiving regular controlled substance analgesic defined as: codeine with acetaminophen, fentanyl, hydromorphone, meperidine, morphine, oxycodone with acetaminophen, propoxyphene with acetaminophen, and hydrocodone with acetaminophen.

Exclusion Criteria:

  • Admitted to the Pediatric Intensive Care Unit
  • Surgical patients, defined as patients having surgery since admission other than minor procedures
  • Patients anticipated to receive pain medication for less than 24 hours
  • Patients unable to verbally communicate their pain
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00935207

Locations
United States, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
Sponsors and Collaborators
University of Mississippi Medical Center
Investigators
Principal Investigator: Andrew Ostrenga, Pharm.D. University of Mississippi Medical Center
  More Information

No publications provided

Responsible Party: Andrew Ostrenga, Pharmacist, University of Mississippi Medical Center
ClinicalTrials.gov Identifier: NCT00935207     History of Changes
Other Study ID Numbers: 2009-0054
Study First Received: June 17, 2009
Last Updated: May 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Mississippi Medical Center:
Pain
Pediatric Pain
Pain Diary
Pediatric Pain Measurement
Pain Measurement

ClinicalTrials.gov processed this record on June 17, 2013